OTC Healthcare - Czech Republic
OTC Healthcare in the Czech Republic : Market Insight
EXECUTIVE SUMMARY
Continued Good Growth Due to Rising Economic Growth and Awareness Eye Care Boosted by Longer Work Hours and Allergies Zentiva Expands Lead With Wide Range and Reasonable Prices Chemists/Pharmacies Continues to Dominate Continuation of Growth Due to Rise in Self-medication KEY TRENDS AND DEVELOPMENTS
Good Economic Performance Boosts Sales Urbanisation Shapes Growth Limited Distribution Reduces Consumer Access Growing Interest in Health and Wellness Child-specific OTC Healthcare Hindered by High Prices and Low Awareness MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
Table 2 Consumer Expenditure on Health Goods and Medical Services 2001-2006
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 7 Penetration of Private Label by Sector 2002-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Advertising Packaging and Labelling Distribution De-listing or De-reimbursement Vitamins & Dietary Supplements Registration and Classification Generics DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - Czech Republic
Herbacos Bofarma sro - OTC Healthcare - Czech Republic
STRATEGIC DIRECTION KEY FACTS
Summary 2 Herbacos Bofarma sro: Key Facts
Summary 3 Herbacos Bofarma sro: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 Herbacos Bofarma sro: Competitive Position 2006
Medicamenta Vysoke Myto as - OTC Healthcare - Czech Republic
STRATEGIC DIRECTION KEY FACTS
Summary 5 Medicamenta Vysoke Myto as: Key Facts
Summary 6 Medicamenta Vysoke Myto as: Operational Indicators 2004/2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 7 Medicamenta Vysoke Myto as: Competitive Position 2006
Walmark as - OTC Healthcare - Czech Republic
STRATEGIC DIRECTION KEY FACTS
Summary 8 Walmark as: Key Facts
Summary 9 Walmark as: Operational Indicators 2004-2005
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 10 Walmark as: Competitive Position 2006
Zentiva as - OTC Healthcare - Czech Republic
STRATEGIC DIRECTION KEY FACTS
Summary 11 Zentiva as: Key Facts
Summary 12 Zentiva as: Operational Indicators 2005-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 13 Zentiva as: Competitive Position 2006
Eye care in the Czech Republic
OVERVIEW
SECTOR DATA
Table 12 Sales of Eye Care by Subsector: Value 2001-2006
Table 13 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 14 Eye Care Company Shares by Retail Value 2002-2006
Table 15 Eye Care Brand Shares by Retail Value 2003-2006
Table 16 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 17 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011